Antonio Giordano is a medical doctor and a Ph.D. pathologist. Dr. Giordano is arguably best known for his discover of the tumor suppressor gene Rb2/p130. He is the President and Founder of the Sbarro Health Research Organization, an institute for cancer research and molecular medicine. This organization provides students from around the world access to state of the art laboratories at Temple University. Based in Temple University, S.H.R.O. collaborates with the University of Pennsylvania, University of Rome, University of Naples, University of Messina, University of Palermo, and the University of Sassari. Giordano founded the Human Health Foundation (HHF) with Giovannino Antonini, the President of the Spoleto Credito Servizi. The charitable organization raises funds to support biomedical research and health education in Italy. Dr. Giordano has been published in to over 400 peer-review articles in the fields of gene therapy, the epidemiology of cancer, the genetics of cancer, and cell cycle. The recipient of some of the most distinguished international awards, he also serves on the editorial boards of forty professional journals. Giordano is one of seven distinguished Italian Americans board members of the National Italian American Foundation. He has made significant contributions to the field of cancer research and molecular medicine.